Having established the metabolic trajectory of β and α cells in response to glucose in the setting of β cell IAPP toxicity characteristic of T2D in humans, we next sought to relate this to insulin and glucagon secretion in vivo, using the most physiologically relevant glucose challenge: oral glucose. The gene discussed is GCG; the disease is type 2 diabetes mellitus.